Polypharmacy in Psychiatry Practice, Volume I (eBook)

Multiple Medication Use Strategies

Michael S Ritsner (Herausgeber)

eBook Download: PDF

2013 | 2013
XVII, 287 Seiten
Springer Netherland (Verlag)
978-94-007-5805-6 (ISBN)

Infos

Although monotherapy is generally recommended as the treatment of choice, treatment resistance of patients with psychosis, cognitive, mood and anxiety disorders represents a significant clinical problem. In this context, augmentation and combination strategies are commonly employed to address this problem. Although multiple medication use common in psychiatric practice, reasons, efficacy and safety for polypharmacy, and augmentative strategies have remained unclear. It remains unclear if there is an evidence base to support polypharmacy. Furthermore, excessive and inappropriate use of psychotropic medications has been recognized as a public health problem. This volume set is the first comprehensive, clinically oriented, reference on the multiple medication use to treat psychotic, cognitive, mood and anxiety disorders.

Inhalt

About the EditorPreface  ContributorsPart I. Polypharmacy treatment strategies 1. Multiple medication use in psychiatry: How Rational Can It Be? Ahsan Khan and Sheldon Preskorn2. Receptor binding targets for antipsychotic efficacy; Maureen M. Grainger, Rebecca Ahlbrand, Paul S. Horn, Neil M. Richtand3. Drug interactions and polypharmacy; Jessica L. Gören, and Ashley Tewksbury4. Preclinical and clinical investigation of antipsychotic polypharmacy: What is the evidence? Dimitrios Kontis, Eirini Theochari5. Should high dose or very long-term antipsychotic monotherapy be considered before antipsychotic polypharmacy? Stephen M. Stahl and Debbi A. Morrissette6. Multiple Medication Use of Neuropsychiatry in Forensic Psychiatry: Findings from the Central State Forensic Psychiatric Hospital of Saxony-Anhalt; Joachim G. WitzelPart II. Augmentation strategies7. Antipsychotic treatment within a naturalistic trial - how are we treating schizophrenia patients in the "real-world"? Rebecca Schennach, Michael Obermeier, Florian Seemüller, Daniela Krause, Richard Musil, Ilja Spellmann, Hans-Jürgen Möller, Michael Riedel 8. A multi-target drug treatment in schizophrenia using adjunctive agents with non-D2 mechanisms of action; Michael S Ritsner9. Antidepressants in schizophrenia – a place for them? Viacheslav Terevnikov and Grigori Joffe10.  Stressful life events and anticonvulsant medication in psychiatric patients; Petr Bob11.  Multiple medication use in somatic symptom disorders: from augmentation to diminution strategies; Adrian P. MundtAppendix; Rena KursAnnotated bibliography on polypharmacyList of Psychotropic Medications  Contents to Volume II Contributors to Volume IIIndex

Produkt-Details

• Erscheint lt. Verlag: 15.2.2013
• Zusatzinfo: XVII, 287 p. 31 illus., 28 illus. in color.
• Verlagsort: Dordrecht
• Sprache: englisch
• Themenwelt: Geisteswissenschaften ► Psychologie ► Klinische Psychologie
• Themenwelt: Medizin / Pharmazie ► Medizinische Fachgebiete ► Psychiatrie / Psychotherapie
• Themenwelt: Studium ► 1. Studienabschnitt (Vorklinik) ► Biochemie / Molekularbiologie
• Themenwelt: Sozialwissenschaften ► Pädagogik
• Schlagworte: Augmentative strategies • Mental disorders • Polypharmacy • Rehabilitation • Treatment
• ISBN-10: 94-007-5805-7 / 9400758057
• ISBN-13: 978-94-007-5805-6 / 9789400758056